StemCell Institute
TSE:7096

Watchlist Manager
StemCell Institute Logo
StemCell Institute
TSE:7096
Watchlist
Price: 823 JPY -0.6% Market Closed
Market Cap: ¥8.4B

Operating Margin

10.4%
Current
Declining
by 4.8%
vs 3-y average of 15.2%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
10.4%
=
Operating Income
¥356.2m
/
Revenue
¥3.4B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
10.4%
=
Operating Income
¥356.2m
/
Revenue
¥3.4B

Peer Comparison

Country Company Market Cap Operating
Margin
JP
StemCell Institute
TSE:7096
8.3B JPY
Loading...
US
CVS Health Corp
NYSE:CVS
93.3B USD
Loading...
US
Cigna Corp
NYSE:CI
72.3B USD
Loading...
US
Cigna Group
XMUN:CGN
60.5B EUR
Loading...
DE
Fresenius SE & Co KGaA
XETRA:FRE
26.4B EUR
Loading...
DE
Fresenius Medical Care AG
XMUN:FME
22B EUR
Loading...
US
Laboratory Corporation of America Holdings
NYSE:LH
22.4B USD
Loading...
US
Quest Diagnostics Inc
NYSE:DGX
20.3B USD
Loading...
US
Guardant Health Inc
NASDAQ:GH
14B USD
Loading...
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.8B EUR
Loading...
AU
Sonic Healthcare Ltd
ASX:SHL
11B AUD
Loading...

Market Distribution

In line with most companies in Japan
Percentile
69th
Based on 6 730 companies
69th percentile
10.4%
Low
-125 500% — 4.2%
Typical Range
4.2% — 10.6%
High
10.6% — 9 743.7%
Distribution Statistics
Japan
Min -125 500%
30th Percentile 4.2%
Median 7%
70th Percentile 10.6%
Max 9 743.7%

StemCell Institute
Glance View

Market Cap
8.4B JPY
Industry
Health Care

StemCell Institute KK engages in stem cell banking business. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 82 full-time employees. The company went IPO on 2021-06-25. The firm operates Cell Bank business segment. After signing the contract for the separation and storage of umbilical cord blood with customers (pregnant women), the umbilical cord blood collected at domestic umbilical cord blood collection cooperative hospitals (university hospitals, obstetric clinics and others) is collected, and carried into its cell processing center in Minato-ku, Tokyo. The company will be stored at its own cell storage center (Midori-ku, Yokohama, Kanagawa) for a long time at ultra-low temperature after stem cells contained in cord blood being separated, extracted and prepared.

Intrinsic Value
1 260.25 JPY
Undervaluation 35%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
10.4%
=
Operating Income
¥356.2m
/
Revenue
¥3.4B
What is StemCell Institute's current Operating Margin?

The current Operating Margin for StemCell Institute is 10.4%, which is below its 3-year median of 15.2%.

How has Operating Margin changed over time?

Over the last 3 years, StemCell Institute’s Operating Margin has decreased from 14.4% to 10.4%. During this period, it reached a low of 10.4% on Sep 30, 2025 and a high of 17.4% on Jun 30, 2024.

Back to Top